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Abstract
Background: Rapid and reliable diagnostic assays for enteric (typhoid and paratyphoid) fever are urgently needed. We
report the characterization of novel approach utilizing lymphocyte secretions, for diagnosing patients with enteric fever by
the TPTest procedure.
Methodology: TPTest detects Salmonella-specific IgA responses in lymphocyte culture supernatant. We utilized TPTest in
patients with suspected enteric fever, patients with other illnesses, and healthy controls. We also evaluated simplified
modifications of TPTest for adaptation in laboratories with limited facilities and equipment.
Principal Findings: TPTest was positive in 39 (27 typhoid and 12 paratyphoid A) patients confirmed by blood culture and
was negative in 74 healthy individuals. Among 32 individuals with other illnesses, 29 were negative by TPTest. Of 204
individuals with suspected enteric fever who were negative by blood culture, 44 were positive by TPTest and the patients
were clinically indistinguishable from patients with confirmed bacteremia, except they were more likely to be under 5 years
of age. We evaluated simplifications in TPTest, including showing that lymphocytes could be recovered using lysis buffer or
buffy coat method as opposed to centrifugation, that incubation of cells at 37uC did not require supplemental CO2, and that
results were available for majority of samples within 24 hours. Positive results by TPTest are transient and revert to negative
during convalescence, supporting use of the test in endemic areas. The results can also be read using immunodot blot
approach as opposed to ELISA. Since no true gold standard currently exists, we used a number of definitions of true
positives and negatives. TPTest had sensitivity of 100% compared to blood culture, and specificity that ranged from 78–97%
(73–100, 95% CI), depending on definition of true negative.
Conclusion: The TPTest is useful for identification of patients with enteric fever in an endemic area, and additional
development of simplified TPTest is warranted.
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Introduction
Salmonella enterica serotype Typhi and Paratyphi A and B are
human-restricted pathogens and are the causes of enteric fever.
Salmonella enterica serotype Typhi (S. Typhi) infection causes
approximately 20 million cases of enteric (typhoid) fever and over
200,000 deaths annually [1]. Salmonella enterica serotype Paratyphi
A (S. Paratyphi A) infection causes an additional 5 million cases of
enteric (paratyphoid) fever each year [1,2]. S. Paratyphi B are less
common causes of enteric fever. The manifestations of enteric
fever range from non-specific febrile illness, to prolonged illness
characterized by high fever, lymphadenopathy, hepatosplenomeg-
aly, encephalopathy, and complications due to necrosis of ileocecal
lymphoid tissue [3–5]. Although paratyphoid fever was considered
a less severe form of enteric fever, recent longitudinal studies
suggest that clinical manifestations of enteric fever caused by S.
Typhi and S. Paratyphi A are similar [2,6].
In developing countries where typhoid fever is endemic, the
incidence ranges from 25 to 1000 cases/100,000 person-years
[1,7,8]. In highly endemic areas, typhoid fever most commonly
occurs among children 1–5 years of age [4,8–10]. For instance, in
a fever surveillance study in an urban area in Kamalapur in
Dhaka, Bangladesh, the incidence of S. Typhi bacteremia for all
age groups was 390 episodes/100,000 person-years [10]. The
incidence of S. Typhi bacteremia among individuals .5 years of
age was 210 episodes/100,000 person years, and among children
,5 years of age, 1870 episodes/100,000 person-years. Thus,
children ,5 years of age had an 8.9-fold increased risk of infection
when compared with all others (95% CI: 4.9–16.4) [10]. Historical
mortality rates of enteric fever are in excess of 15%, but outcomes
are improved in the setting of appropriate antibiotics and
supportive care [11–13]. The management of patients with enteric
fever is confounded by the non-specific clinical presentation,
inadequate current diagnostic tests, and widespread antibiotic
resistance.
The most commonly used diagnostic assay for typhoid fever
globally is the Widal test, developed over a century ago, but the
Widal assay is neither sensitive nor specific for diagnosing patients
with typhoid fever [14–16]. Blood cultures are not routinely used
in resource-poor countries, and are only 30–70% sensitive
[1,17,18]. Other assays that have been evaluated include
nucleotide amplification assays, and a number of antibody-based
detection systems including ELISA, dot blot immunoassay,
hemagglutination, coagglutination, and counter immune electro-
phoresis. Many of these assays lack sensitivity and/or specificity in
areas of the world endemic for enteric fever and Salmonella
infections [19–21]. For instance, commercially available rapid tests
for typhoid, including Typhidot, Tubex, latex agglutination assay,
immuno-chromatographic lateral flow assays and dip stick assays
have low utility in identifying patients with enteric fever at the
acute stage of disease in endemic zones, when the ability to make a
diagnosis is most important [22–24]. The sensitivity and specificity
of conventional diagnostic methods (blood culture and Widal test)
for paratyphoid fever is also comparably low [25–27]. A reliable
diagnostic method that could be used during the acute phase of
both typhoid and paratyphoid fever is therefore needed.
We have previously shown that we could detect IgA antibodies
targeting Salmonella enterica serotype Typhi in the blood of patients
with typhoid fever in Bangladesh, using a lymphocyte culture
supernatant (ALS)-based system that targeted serotype Typhi
membrane preparation (MP) as target antigen. This assay takes
advantage of the transient systemic migration of activated
lymphocytes after infection, allowing recovery of antigen-specific
lymphocytes in the peripheral circulation. Using this assay, we
showed that all (100%) blood culture confirmed typhoid fever
patients were detected by this technique [28]. Since this method
requires the ex-vivo culturing of isolated lymphocytes and ELISA,
we focused our efforts on simplifying the technique, and we also
extended our analysis to patients with paratyphoid fever, the other
major cause of enteric fever in South Asia, where S. Paratyphi A
accounts for up to 20% of cases of enteric fever [1,2,29]. We refer
to this assay as the TPTest (typhoid and paratyphoid fever test).
Materials and Methods
Study population and sample collection
We enrolled individuals (n = 243) presenting for care at the
Kamalapur icddr,b field station with 3–7 days of fever$39uC who
were clinically suspected to have enteric fever for whom no
alternate diagnosis was evident Kamalapur is a densely populated
area in Dhaka, Bangladesh [10]. At enrollment, we collected
venous blood (5 ml from young children and 10 ml from others)
for microbiologic culture and antimicrobial susceptibility testing,
as well as for analysis by the TPTest.
We also collected blood from the patients (n = 32) who were
positive by relevant laboratory techniques for other febrile
illnesses, and we analyzed these specimens using the TPTest.
We also enrolled healthy controls (n = 74; 25 adults, 25 older
children and 24 young children) from the same endemic zone but
without any acute illness, and analyzed their blood by the TPTest
[28]. All specimens were collected from the participants between
August 2008 to November 2011.
Ethics statement
This study was approved by the research review and the ethical
review committees of the icddr,b and informed written consent
was obtained from guardians of child participants (1–17 years) and
adult participants (18–59 years) provided their own consent.
Isolation of organisms from blood cultures
Blood (3 ml for children ,5 years of age and 5 ml from others)
was collected and cultured using the automated BacT/Alert
method [28], followed by sub-culture on MacConkey agar, blood
agar and chocolate agar plates and incubation overnight at 37uC.
Organisms were identified on the basis of growth characteristics,
colony morphology, microscopic examination of Gram stained
Author Summary
Salmonella enterica serotype Typhi and Paratyphi A are
responsible for typhoid and paratyphoid fever respectively
and the disease caused is known generally as enteric fever.
Appropriate and early diagnosis of the disease is important
for initiation of treatment of the patient with a suitable
antibiotic. The performance of the available diagnostic
methods take time and as well as have low sensitivity and
specificity. We describe here an immunodiagnostic assay,
the TPTest, which is based on the use of secretions of
antibodies from peripheral blood lymphocytes. We de-
scribe simplifications of the procedure and show that the
assay has as a sensitivity of 100% with a specificity that
ranges from 78–97% (73–100, 95% CI) for detecting
patients with typhoid and paratyphoid fever in an enteric
fever endemic zone. The TPTest uses a small blood
volume, and reverts to negative by convalescence,
supporting its further development as a relatively low
cost assay to diagnose patients with enteric fever in
endemic zones.
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smear, biochemical tests and by slide agglutination tests with
Salmonella-specific anti-sera (Denka Sieken, Tokyo, Japan) [28,30].
Diagnosis of enteric fever by TPTest
Peripheral blood mononuclear cells (PBMCs) from venous
blood were isolated by density gradient centrifugation on Ficoll-
Isopaque (Pharmacia, Uppsala, Sweden), and obtained superna-
tants from cultured lymphocytes as previously described [28].
Briefly, unstimulated PBMCs were cultured at 107 cells/ml in
RPMI complete medium [RPMI 1640 (Gibco, Gaithersburg, MD)
with 10% heat-inactivated fetal bovine serum (HyClone, Ogden,
UT), 100 mg of streptomycin/ml, 100 U of penicillin/ml, 100 mM
pyruvate, and 200 mM L- glutamine (Gibco) [28,31] at 37uC in an
incubator with 5% CO2 supply. After incubation for various times,
IgA antibodies specific to S. Typhi membrane preparation (MP)
were measured in the culture supernatants by enzyme-linked
immunosorbent assay (ELISA) method as previously described
[28]. Briefly, the wells of microtiter plates (Nunc F; Nunc,
Denmark) were coated with MP antigen (10 mg/ml; see below for
preparation). After overnight incubation at room temperature, the
plates were blocked with 1% bovine serum albumin (BSA) in PBS.
A 100 ml of diluted (1:2 dilution with 0.1% BSA-PBS-Tween)
culture supernatant was added to each well and incubated the
plates at 37uC for 90 min. After washing with 0.05% PBS-Tween,
the horseradish peroxidase conjugated antibodies to human IgA
(Jackson Laboratories, Bar Harbor, ME) were added and the
plates were developed with ortho-phenylene diamine (Sigma
Chemical Co., St. Louis, MO) in 0.1 M sodium citrate buffer and
0.1% hydrogen peroxide and then read kinetically at 450 nm for
five minutes at 19-second intervals. The maximal rate of optical
density change was expressed as milli optical density absorbance
units per minute (mAB/min). To avoid the discrepancy among
plates, the mAB/min kinetic reaction rate of test samples was
divided by that of a standard comprised of pooled convalescent
phase sera previously collected from patients with documented S.
Typhi bacteremia in Dhaka, Bangladesh, and the product was
multiplied by 100 and was expressed as ELISA units [28]. The cut-
off value of the TPTest was calculated as greater than the
geometric mean ELISA units, plus two standard deviations, of
samples from healthy endemic zone controls (a positive value was
thus defined as .10 ELISA units). The initial TPTest used culture
supernatants collected after 48 hours of incubation. For 20
patients, the TPTest was also carried out after incubation of
lymphocytes for 24 hours as well as 48 hours. For 30 patients aged
younger than 5 years, we used one ml of venous blood to perform
the TPTest.
Preparation of the S. Typhi antigen used in TPTest
The MP antigen used for the TPTest was prepared using the
procedure described previously using S. Typhi strain Ty21a
[28,32]. The bacterial strain was cultivated on sheep blood agar
plates and the bacteria harvested in buffer (5 mM MgCl2, 10 mM
Tris [pH 8.0]). The bacterial suspension was sonicated for five
times at 60% amplitude and centrifuged at 14006 g for
10 minutes. The supernatant was then transferred to fresh tubes
and centrifuged at 149006 g for 30 minutes. The pellet was
dissolved in harvest buffer and the protein content was determined
by the Bio-Rad protein assay and stored at 270uC.
Adaptation of the TPTest procedure for transfer to
resource-limited settings
In an attempt to simplify the TPTest, we also assessed a number
of modifications to the procedure and compared these results with
the above described assay. To simplify PBMC recovery, in
addition to isolating cells by density gradient centrifugation on
Ficoll-Isopaque, we also isolated PBMCs using erythrocyte lysis
buffer and separately using a crude leukocyte buffy coat (both
approaches described below). We tested 25 specimens by all three
cell separation methods for comparison. In order to assess whether
incubation of PBMCs required the presence of supplemental CO2,
we also compared TPTest results using supernatants recovered
from unstimulated leukocytes cultured at 37uC in the presence and
absence of 5% CO2. We also assessed the ability of immunodot
blot assays to detect differences in samples, comparing results to
the ELISA-based system.
Separation of cells by RBC lysis
We diluted venous blood with lysing solution (0.15 M ammo-
nium chloride; 1 mM potassium bicarbonate and .01 mM
disodium EDTA) at 1:10 dilution and mixed the sample by gently
inverting the tube (BD Falcon) 3–5 times. We held the tube for
5 minutes at room temperature, and we then centrifuged the
samples at 9506 g for 10 minutes at 20uC. We decanted the
supernatant and resuspended the cells in RPMI complete medium
and counted in a haemocytometer. We re-centrifuged as above,
and resuspended the isolated cells in RPMI complete medium to a
concentration of 107 cells/ml. We aliquoted the suspended cells
into wells of tissue culture plates (F96 MicroWell Plate, Nunc) and
incubated them at 37uC with and without 5% CO2 for 24–
48 hours. We then harvested the culture suspension, centrifuged
the samples at 116006g at 20uC for 5 minutes, and collected the
supernatant.
Separation of cells by buffy coat procedure
We collected venous blood in sodium citrate tubes (Greiner bio-
one, Vacuette, North America) and centrifuged these at 7506 g
for 5 min at 20uC. After removing the plasma from the top layer,
we collected the buffy coat using a Pasteur pipette. We then
washed the cells twice with phosphate-buffered saline (PBS;
10 mM; pH-7.2) and resuspended the cells in RPMI complete
medium to a concentration of 107 cells/ml and incubated the cells
as above at 37uC with and without 5% CO2 for 24–48 hours. We
then harvested the culture suspension, centrifuged the samples at
116006 g at 20uC for 5 minutes, and collected the supernatant.
Assessment of TPTest ELISA system at different time
points of illness
To assess whether the TPTest remained positive over the course
of the illness and recovery, we also assessed TPTest reactivity on
days 7 and 21 in 38 patients who were positive for the TPTest
(.10 ELISA unit) at the day of enrollment. Among these 38
patients, 18 patients were positive by both blood culture (17
patients had S. Typhi bacteremia and one had S. Paratyphi A
bacteremia) and TPTest, and rest of the patients were positive only
by the TPTest.
To assess the reproducibility of the TPTest, we also randomly
selected 10 adult patients from the 243 enrolled who were negative
for both blood culture and TPTest on enrollment, and repeated
the TPTest on days 7 and day 21 after enrollment.
Immunodot blot assay
To preliminarily evaluate whether an immunodot blot system
could be developed for use in settings lacking ELISA capability, we
also assessed an immunodot blot-based approach. To do this, we
divided strips of 30630 cm Osmonics NitroBind 0.45 mm
Transfer Membrane (Krackeler Scientific, Inc, Albany, New
Enteric Fever Diagnosis Using Lymphocyte Secretion
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York) into 0.35 by 0.35 cm squares. We soaked these strips in PBS
and allowed the membranes to dry before coating them with 1 ml
of MP antigen (1 mg/ml MP antigen dissolved in PBS), 1 ml of
AffiniPure Goat Anti-Human IgG, F(ab9)2 Fragment (1.8 mg/ml
dissolved in deionized water) as a positive control or 1 ml of
lipoolysaccharide (LPS) of Vibrio cholerae O1 X-25049 strain
(Ogawa) (1 mg/ml dissolved in PBS) as a negative control at
room temperature for 5 minutes. We then blocked the membranes
with 1% bovine serum albumin in PBS at room temperature for
20 minutes using slow shaking (230 rpm; Gyrotory Water Bath
Shaker; New Brunswick Scientific). We discarded the blocking
solution and washed the membranes twice with PBS. To assess
immuno-reactivity, we added lymphocyte supernatants diluted 1:2
with 0.1% BSA-PBS-0.05% Tween to membranes and incubated
these for 3 hours at room temperature with slow shaking
(230 rpm; Gyrotory Water Bath Shaker; New Brunswick Scien-
tific). We then washed the membranes five times with PBS-Tween
(0.05%) and once with PBS. We then incubated the membranes
with rabbit anti human IgA conjugated to horse radish peroxidase
(Jackson Immnoreaserch Laboratories, Inc. West Grove. USA at a
1:500 dilution in 0.1% BSA-PBS-Tween) for 1.5 hours at room
temperature with shaking. We washed the membrane five times
with PBS-Tween (0.05%) and once with PBS. We developed the
membranes by adding H2O2- 4-chloro- 1-naphthol, prepared by
dissolving 1.7 ml 4-chloro- 1-napthol (3 mg/ml in 99.9% meth-
anol) in 8.3 ml of Tris buffered saline (TBS; 20 mM Tris; 0.5 M
NaCl; pH-7.5), to which 0.015% H2O2 was added immediately
before use. Reactivity was read at 5 minutes. Membranes were
then washed with water and air dried. We considered immunodots
positive if reactivity could be seen with the naked eye after
membranes had dried. Dots were independently read by two
technicians with 100% concordance.
Statistical analysis
We used SigmaStat (version3.1) and Prism4, EpiInfo (version
2000; Centers for Disease Control and Prevention) for data
management, analysis, and graphical presentation. We performed
statistical evaluation of differences among groups by using the
Mann-Whitney U test and considered results statistically signifi-
cant if p,0.05. We have calculated the sensitivity and specificity




Out of 243 enrolled patients suspected of having enteric fever,
59 were adults (18–59 years of age), 108 were older children (6–17
years of age) and 76 patients were young children (1–5 years of
age). We isolated S. Typhi or S. Paratyphi A in the blood of 27
(11%) and 12 (5%) patients, respectively. Among 27 patients
bacteremic with S. Typhi, 18 (67%) were older children, 7 (26%)
were younger children, and 2 (7%) were adults. Among 12 patients
bacteremic with S. Paratyphi A, 9 (75%) were older children and
the remaining 3 (25%) were young children. The initiation of
antimicrobial therapy was at the discretion of the attending
physician; however, many individuals with suspected enteric fever
received empiric treatment with a third generation cephalosporin
such as oral cefixime or parenteral ceftriaxone for 14–21 days,
including all patients subsequently reactive in the TPTest (see
below). All patients recovered, and there were no deaths or severe
complications in this cohort.
Categories of the study participants
For analyses, we categorized the individuals studied into four
groups (Table 1) as follows- Group I- patients with suspected
enteric fever and confirmed bacteremia with S. Typhi or S.
Paratyphi A organisms (n = 39); Group II- patients with clinical
characteristics compatible with enteric fever, but in whom blood
cultures remained negative (n = 204); Group III- patients con-
firmed by relevant methods to have other illnesses (n = 32; dengue
(n= 15), leptospirosis (n = 1), Streptococcus pneumoniae bacteremia
(n = 1), tuberculosis (n = 7), visceral leishmaniasis (n = 5), respira-
tory tract infection (n= 1), acute hepatitis B infection (n= 1) and
acute hepatitis E virus (n = 1) infection. Blood culture was carried
out in patients with other illnesses except those with tuberculosis
and visceral leishmaniasis. Group IV- healthy endemic zone
controls (n = 74).
Results of the TPTest
As shown in table 1, all patients with confirmed S. Typhi or S.
Paratyphi A bacteremia (Group I) were positive in the TPTest.
Among 204 suspected of having enteric fever but blood culture
negative (Group II), 44 patients were positive by the TPTest. The
TPTest was positive in 3 out of 32 patients with other illnesses
(Group III). Of these three TPTest positive patients, one was
bacteremic for S. pneumonie, one had acute dengue fever, and one
had visceral leishmaniasis. None of the 74 healthy endemic zone
controls (Group IV) were positive by the TPTest. One ml of blood
was sufficient for carrying out the TPTest in 30 patients less than
five years of age.
Clinical characteristics of patients with suspected enteric
fever who were blood culture positive compared with
those who were blood culture negative but TPTest
positive
Clinical characteristics of patients in these groups are presented
in Table 2. Of patients with confirmed S. Typhi or S. Paratyphi A
bacteremia, 21 were male and 18 female. Of patients with a
Table 1. TPTest results in different study groups.
Group Characteristics No. of individuals TPTest positive* TPTest negative
Group I Clinically suspected enteric fever, blood culture grew S. Typhi 27 27 0
Clinically suspected enteric fever, blood culture grew S. Paratyphi A 12 12 0
Group II Clinically suspected enteric fever but blood culture negative 204 44 160
Group III Confirmed illness other than enteric fever 32 3 29
Group IV Healthy control 74 0 74
*.10 ELISA unit was considered a positive TPTest (see text).
doi:10.1371/journal.pntd.0002316.t001
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positive TPTest and negative blood culture, 22 were male and 22
female. Of the 243 patients with suspected enteric fever, 23 (9.5%)
individuals had taken antibiotics before enrollment. Of these, three
patients were positive by blood culture, whereas eight individuals
were positive only by the TPTest. The number of young children
(,5 years of age) between the blood culture and TPTest positive
group (39) and the blood culture negative but TPTest positive
group (44) was significantly different (p = 0.01), with negative
blood cultures being more common in young children. No other
differences were detected among the groups.
Sensitivity and specificity of the TPTest
The sensitivity and specificity of the TPTest are shown in
Table 3. Considering blood culture-confirmed cases as positive
and the patients with other illnesses and healthy controls as
negative for enteric fever , the sensitivity and specificity of the
TPTest were 39/39 (100%) and 103/106 (97%; 95% confidence
interval, CI: 94–100), respectively. Considering blood culture-
confirmed cases as positive and blood culture-negative patients as
enteric fever negative, the TPTest was 39/39 (100%) sensitive and
160/204 (78%, 95% CI: 73–84) specific. Considering blood
culture-confirmed cases as positive and the patients negative by
blood culture, patients with other illness and healthy controls as
enteric fever negative, the sensitivity and specificity of the TPTest
were 39/39 (100%) and 263/310 (85%, 95% CI: 81–89).
Comparison of the results of the TPTest using
lymphocyte supernatants harvested after 24 and
48 hours of culture
For 28 patients, we performed the TPTest using lymphocyte
culture supernatants collected at both 24 and 48 hours (p = 0.231)
of incubation. Among these, 14 patients were positive for the
TPTest (.10 ELISA unit) following 48 hours of incubation. Of
these, 9 (64%) test results were positive following 24 hours (and
remained positive after 48 hours), and 5 (36%) were negative at
24 hours but became positive at 48 hours of incubation (Figure 1).
All negative samples using fluid collected at 48 hours (n = 14) were
also negative using the 24 hour supernatants.
Results of the simplified TPTest
We found no significant differences (p = 0.805 to p= 0.935)
comparing TPTest results using PBMCs separated by RBC lysis or
buffy coat procedure, compared to cells separated by density
gradient centrifugation (Figure 2A). Similarly, we did not detect
significant differences (p = 0.311) in MP-IgA values in lymphocyte
supernatant fluid when the PBMCs were cultured in an incubator
Table 2. Clinical characteristics of study participants.
Characteristics
Patients with confirmed S. Typhi
or S. Paratyphi A bacteremia
(Total no. = 39) no. (%)
Clinically suspected enteric fever,
blood culture negative but TPTest
positive (Total no. =44) no. (%)
Number of male 21 (54) 22 (50)
Children ,5 years of age 10 (26) 23 (52)a
Duration of fever, days (median) (25th, 75th percentile) 4 (3, 5) 4 (3, 5)
Temperature in uC (median) (25th, 75th percentile) 39.2 (39.1, 39.5) 39.2 (39.0, 39.4)
Prior antibiotic intake 3 (8) 8 (18)
Hospitalization 2 (5) 0 (0)
Headache 6 (15) 12 (27)
Coated tongue 10 (26) 11 (25)
Myalgias 6 (15) 11 (25)
Abdominal pain 7 (18) 13 (30)
Tender abdomen 3 (8) 0 (0)
Constipation 4 (10) 3 (7)
Diarrhea 3 (8) 7 (16)
Loss of appetite 17 (44) 14 (32)
aSignificantly different (p,0.05) when compared blood culture confirmed bacteremia.
doi:10.1371/journal.pntd.0002316.t002
Table 3. Sensitivity, specificity (with 95% confidence intervals in parenthesis) of TPTest for diagnosing enteric fever.
Parameters Sensitivitya (%) Specificitya (%)
Considering blood culture-confirmed cases as positive and the patients with other illness and healthy
controls as negative for enteric fever
39/39 (100) 103/106 (97, CI: 94–100 )
Considering blood culture-confirmed cases as positive and blood culture-negative patients as
enteric fever negative
39/39 (100) 160/204 (78, CI: 73–84)
Considering blood culture-confirmed cases as positive and the patients negative by blood culture,
patients with other illness and healthy controls as enteric fever negative
39/39 (100) 263/310 (85, CI: 81–89)
aCalculated using a two by two table.
doi:10.1371/journal.pntd.0002316.t003
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with supplemental 5% CO2 or without CO2 (Figure 2B). Using the
immunodot blot assay, we detected MP-IgA antibodies in
lymphocyte supernatants utilizing nitrocellulose membranes
(Figure 3). We tested the immunodot blot assay in 23 positive
specimens (.10 ELISA unit in TPTest) and in 5 negative
specimens (,10 ELISA unit in TPTest). TPTest specimens with
values $16 ELISA units were detected by the immunodot blot
assay. None of the specimens negative by the TPTest specimens
was positive by the dot blot method.
Duration of TPTest responses
To assess the duration of TPTest responses, we collected blood
from later stages of illness (days 7 and 21) from 38 patients with a
positive TPTest at the time of presentation. Of these, 32 (84%)
patients converted to a negative result by day 21:18 (56%) patients
became negative by day 7, and the additional 14 (44%) became
negative by day 21, suggested that the TPTest assesses a transient
response in enteric fever. Among six patients who failed to revert
to negative by day 21, five (83%) were positive for S. Typhi
bacteremia and one was positive by the TPTest only.
Among 10 patients negative by TPTest at clinical presentation,
all 10 remained negative at days 7 and 21.
Figure 1. Effect on TPTest results of different incubation
periods of cells. The TPTest was done using lymphocyte supernatants
after 24 and 48 hours incubation of peripheral blood mononuclear cells
(PBMCs) at 37uC with supplemental CO2. .10 ELISA units was
considered a positive TPTest.
doi:10.1371/journal.pntd.0002316.g001
Figure 2. Comparison of TPTest results using various techniques. (A) The TPTest was carried out using leukocytes recovered by various
techniques: density gradient centrifugation, erythrocyte lysis buffer, and buffy coat separation. The Mann-Whitney U test was used to compare the
responses of different blood cell separation methods. RBC, red blood cell. (B) Comparison of TPTest results using peripheral blood mononuclear cells
incubated at 37uC in the presence or absence of supplemental CO2. .10 ELISA units was considered a positive TPTest (see text).
doi:10.1371/journal.pntd.0002316.g002
Figure 3. Comparison of Salmonella specific IgA responses
using ELISA on lymphocyte secretions versus immunodot blot
approaches. Anti-Salmonella membrane preparation (MP) specific IgA
responses using ELISA on lymphocyte secretions was compared to
immunodot blot approaches. ELISA positive defined as .10 ELISA units
(see text). Immunodot blot approaches positive in settings of$16 ELISA
units. Positive antigen (Ag): AffiniPure Goat Anti-Human IgG, F(ab9)2
Fragment. Negative antigen (Ag): LPS of Vibrio cholerae O1 X-25049
strain (Ogawa).
doi:10.1371/journal.pntd.0002316.g003
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Discussion
There is an urgent need for an improved diagnostic assay for
enteric fever [25]. Microbiologic culturing of peripheral blood
requires 3–10 ml and is only 30–70% sensitive [1,3,10,33].
Obtaining this volume of blood from young children for a single
test is often problematic. The low sensitivity in part reflects the low
bacterial burden in peripheral blood during enteric fever (median
0.1–1.0 CFU/ml) [34], the less than optimal volume of blood
usually obtained in clinical settings, especially from young
children, and the inhibitory effects of insufficient antibiotics that
many patients ingest before seeking medical care. Microbiologic
analysis of a bone marrow aspirate is often considered a ‘‘gold
standard’’, but aspiration of marrow is not clinically practical or
acceptable in many settings, and microbiologic culturing of
marrow in patients who ingest antibiotics prior to clinical
presentation may also be falsely negative. Since the increased
sensitivity of marrow is due to the approximately ,10-fold higher
bacterial load in marrow versus peripheral blood [17,22,35],
culturing a larger volume of blood should be equivalent to
culturing marrow, but fundamentally the problem inherent in all
diagnostic assays for enteric fever based on microbiologic detection
of bacteria is one of a very low clinically accessible bacterial
burden.
To overcome such shortcomings, assays based on amplification
of bacterial nucleic acids have been the focus of many
investigations [25,36–38], since theoretically, such an approach
could have the ability to detect a single organism (living or dead).
Unfortunately, the development of such an approach has also not
yet been successful. The reasons for this are not clear, but may also
relate to the requirement once again for relatively large volumes of
blood, the difficulty of detecting extremely low levels of bacterial
DNA and/or RNA in the blood, especially in the presence of
comparably overwhelming amounts of eukaryotic DNA and RNA,
and the effects of reaction inhibitors present in human blood [39–
41].
Since assays based on directly detecting S. Typhi and S.
Paratyphi have such significant shortcomings, alternative ap-
proaches have focused on detecting human responses to the
bacteria, and indeed, such approaches are the bases of current and
the commercially available serum antibody-based Widal and anti-
lipopolysaccharide and anti-Salmonella enterica assays [14,42,43].
Unfortunately, the utility of these assays has been markedly limited
in areas of the world endemic for enteric fever, since many
individuals in these zones have been previously exposed to S.
Typhi and S. Paratyphi, and have persistently positive assays from
previous exposure [44–46]. Additional approaches currently being
evaluated include assessing cytokine profiles in the blood of
patients in the acute phase of enteric fever, or cellular responses
during the acute stage of infection, including assessing interferon-
gamma release assays [47].
Because of the shortcomings of current enteric fever diagnostic
assays, we were particularly interested in assessing whether we
could pursue an alternative approach and take advantage of the
fact that following recent infection activated antigen-specific
lymphocytes transiently circulate in the peripheral circulation
and could be detected there [28]. In support of this, we have
previously found that measuring anti-Salmonella serum IgA
antibodies in patients was only sensitive for detecting S. Typhi
bacteremia in 81%, but that we could improve those results by
harvesting PBMCs and analyzing antibodies following ex vivo
culturing of the recovered lymphocytes [28]. Importantly, we
found that such an approach did not require in vitro stimulation of
the recovered lymphocytes, presumably because the cells had
already been stimulated in vivo during the acute infection. We
hypothesized that detecting such antigen-specific circulating
lymphocytes would improve specificity, since stimulated lympho-
cytes should de facto be most prominent in individuals actively
infected with S. Typhi and S. Paratyphi. We further hypothesized
that such an approach might be particularly useful in enteric fever
endemic zones, where many individuals might be immunologically
primed to mount a detectable response without ex vivo antigen-
specific stimulation. Indeed, using such an approach, we
previously found in a small pilot study in Dhaka, Bangladesh, a
typhoid fever endemic area, that we could identify 100% of
patients who were bacteremic with S. Typhi, by examining
supernatants recovered from harvested and unstimulated lympho-
cytes for IgA antibodies reactive with an S. Typhi membrane
preparation [28].
In this current and larger study, we extend these findings and
confirm that such an approach not only identifies all patients
bacteremic with S. Typhi, but also all patients bacteremic with S.
Paratyphi A using the same membrane preparation (MP) antigen
recovered from S. Typhi Ty21a strain and using similar
specimens. Previously performed mass spectrometric analysis
reveals that MP contains many Salmonella eneterica proteins related
to energy metabolism, virulence and pathogenesis [48]. The fact
that the majority of patients with a positive TPTest became
negative by day 21 also supports the assumption that the assay
detects recently stimulated and transiently migrating lymphocytes.
Recognizing that enteric fever is largely a disease of resource-
limited settings, we also tried a number of simplifications to our
assay approach. Our data suggests that cells can be recovered from
peripheral blood using an erythrocyte lysis buffer, buffy coat
preparation and incubated at 37uC with no supplemental CO2,
with similar results. We also found that supernatants could be
assayed at both 24 and 48 hours, to identify positive responses as
quickly as possible. We did not find any significant difference in
severity of disease or blood culture positivity among patients who
were TPTest positive and those who were not positive at the early
time point but then became positive at the later time point. We
could accurately identify the vast majority of positive TPTest
responses using an immunodot-based assay as well as the ELISA
format, suggesting that development of a lateral flow device or
dipstick-based assay based on looking for antigen-specific IgA in
lymphocyte supernatants could be possible.
Our study has a number of limitations. The most important is
that there is no true practical gold standard for enteric fever
against which we can assess the TPTest. Serologic tests are not
helpful in enteric fever endemic zones, nucleotide amplification
assays are currently not sensitive, reproducible, standardized or
useful, microbiologic culturing of blood is not sensitive, and
microbiologic culturing of bone marrow is not clinically accept-
able. In this study, if we defined our true positives as individuals
with confirmed bacteremia, and defined our true negatives as
those with confirmed ‘‘other diagnoses’’ including healthy control,
the TPTest would have a sensitivity of 100% and specificity of
97% (95% CI: 94–100). At the other end of the spectrum, if we
defined our true positives as individuals with suspected enteric
fever and confirmed bacteremia, and defined our true negatives as
individuals with suspected enteric fever but a negative blood
culture alone or a negative culture and patients with other
confirmed illnesses and healthy controls, the TPTest would retain
a sensitivity of 100%, but specificity would fall to 78% (95% CI:
73–84) and 85% (95% CI: 81–89), respectively, still a significant
advance over current assays.
False positive results were seen in three patients with other
illnesses. Among these, one patient was categorized as an acute
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dengue infection based on a positive IgM for acute dengue fever ;
however, this individual also had a positive Widal test with a TH
antibody titer $1:320. This patient was treated with cefixime by
the clinical service and recovered. The other two false positive
patients had confirmed S. pneumonie bacteremia or a positive
antibody consistent with a diagnosis of visceral leishmaniasis; these
patients were treated accordingly and recovered. The TPTest
appears to have been falsely positive in these two acutely febrile
individuals, although the chronic S. typhi or S. Paratyphi carrier
status of these two individuals is unknown; an issue that will
require further evaluation.
Recognizing that blood culture sensitivity for enteric fever often
approximates 50% in clinical practice, our identification of
roughly equal numbers of patients with a positive blood culture
and positive TPTest (n = 39) and positive TPTest and negative
blood culture (n = 44), suggests that some or all of these patients
may actually have had enteric fever, especially since these two
groups were largely clinically indistinguishable and that both
clinically improved following therapy that targeted enteric fever.
Of interest is the observation that a positive TPTest but negative
blood culture was more common in children under 5 years of age
compared to older individuals. Although young children have a
higher bacterial load of Salmonella enterica than older individuals in
peripheral blood [34], in our experience the smallest volume of
blood is often collected for microbiologic analysis in young
children. Of note, the TPTest is performed on 1 ml of blood, an
attribute that makes the assay attractive for use in young children.
At present, the TPTest has significant shortcomings. It is not
point-of-care, although our data suggest that it could be performed
by a rudimentary laboratory with minimally trained personnel.
The TPTest also does not provide microbiologic identification to
the species level (S. Typhi versus S. Paratyphi) and does not
provide antimicrobial susceptibility profiles. Similarly, the assay
currently uses a crude membrane preparation of S. Typhi as target
antigen, and pooled convalescent blood to standardize the ELISA,
both of which are areas of ongoing investigation. Also, we have not
yet tested this method in S. Typhi and S. Paratyphi chronic
carriers. Despite these shortcomings, our results suggest that an
assay based on detecting anti-Salmonella IgA antibodies produced
by transiently circulating and activated lymphocytes may hold
significant promise as a platform approach to identify individuals
with enteric fever, including in endemic zones. Our data also
suggest that such an approach could be performed in resource-
limited settings, requiring only 1 ml of blood, facilitating its use in
young children, and with results available within 24–48 hours. Of
note, the TPTest could be used either as a clinical diagnostic tool
to inform treatment approaches for individual patients, as well as a
surveillance tool to estimate disease burden and assist in control
programs targeting enteric fever. As such, we believe these results
support further development of this diagnostic approach.
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